Obstetrics/Gynecology— FDA advisory panel OB

The OB/GYN panel spans reproductive health across diagnostics, monitoring, and surgery: fetal heart monitors and cardiotocographs, colposcopes and hysteroscopes, endometrial ablation systems, laparoscopic instruments for gynecologic procedures, breast pumps, menstrual devices, and assisted-reproduction laboratory equipment. Fetal monitoring is the panel's longest-running product family, with predicate chains reaching back to the earliest years of the 510(k) program.

Recent panel dynamics track two broader currents. The femtech wave has widened the applicant base with consumer-oriented cycle-tracking, pelvic-floor, and lactation devices — many clearing under long-established codes despite novel form factors. And energy-based gynecologic devices carry instructive regulatory history: indications in this space have been the subject of prominent FDA safety communications, a reminder to read cleared indications closely rather than inferring them from how a device is marketed.